CoChat

Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice

Open access
Han, Yang, Gao, Chunhong, Wang, Hao, Sun, Jiejie, Liang, Meng, Feng, Ye, Liu, Qianqian, Fu, Shiyao, Cui, Lin, Gao, Chunsheng, Li, Yi, Yang, Yang, Sun, Baoshan · 2021 · Bioactive Materials
Cited by 197

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Neuronal mitochondrial dysfunction caused by excessive reactive oxygen species (ROS) is an early event of sporadic Alzheimer's disease (AD), and considered to be a key pathologic factor in the progression of AD. The targeted delivery of the antioxidants to mitochondria of injured neurons in brain is a promising therapeutic strategy for AD. A safe and effective drug delivery system (DDS) which is able to cross the blood-brain barrier (BBB) and target neuronal mitochondria is necessary. Recently, bioactive materials-based DDS has been widely investigated for the treatment of AD. Herein, we developed macrophage (MA) membrane-coated solid lipid nanoparticles (SLNs) by attaching rabies virus glycoprotein (RVG29) and triphenylphosphine cation (TPP) molecules to the surface of MA membrane (RVG/TPP-MASLNs) for functional antioxidant delivery to neuronal mitochondria. According to the results, MA membranes camouflaged the SLNs from being eliminated by RES-rich organs by inheriting the immunological characteristics of macrophages. The unique properties of the DDS after decoration with RVG29 on the surface was demonstrated by the ability to cross the BBB and the selective targeting to neurons. After entering the neurons in CNS, TPP further lead the DDS to mitochondria driven by electric charge. The Genistein (GS)- encapsulated DDS (RVG/TPP-MASLNs-GS) exhibited the most favorable effects on reliveing AD symptoms in vitro and in vivo by the synergies gained from the combination of MA membranes, RVG29 and TPP. These results demonstrated a promising therapeutic candidate for delaying the progression of AD via neuronal mitochondria-targeted delivery by the designed biomimetic nanosystems.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bioactmat.2020.08.017

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Keil, 2006, Mitochondrial dysfunction induced by disease relevant A beta PP and tau protein mutations, J. Alzheim. Dis., 9, 139, 10.3233/JAD-2006-9206 · DOI · Paper page
  2. Pratico, 2008, Evidence of oxidative stress in alzheimer's disease brain and antioxidant therapy lights and shadows, Mitochondria Oxidative Stress Neurodegen. Disord., 1147, 70
  3. Pacelli, 2015, Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons, Curr. Biol., 25, 2349, 10.1016/j.cub.2015.07.050 · DOI · Paper page
  4. Du, 2010, Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model, Proc. Natl. Acad. Sci. U.S.A., 107, 18670, 10.1073/pnas.1006586107 · DOI · Paper page
  5. Battogtokh, 2018, Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives, Acta Pharm. Sin. B, 8, 862, 10.1016/j.apsb.2018.05.006 · DOI · Paper page
  6. Han, 2020, Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems, Drug Deliv., 27, 502, 10.1080/10717544.2020.1745328 · DOI · Paper page
  7. Yang, 2020, Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer's disease, Biomaterials, 238, 10.1016/j.biomaterials.2020.119844 · DOI · Paper page
  8. Zeng, 2004, Genistein ameliorates beta-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis, Free Radical Biol. Med., 36, 180, 10.1016/j.freeradbiomed.2003.10.018 · DOI
  9. Kohara, 2015, Genistein improves spatial learning and memory in male rats with elevated glucose level during memory consolidation, Physiol. Behav., 140, 15, 10.1016/j.physbeh.2014.12.005 · DOI
  10. Wu, 2010, Solubility of genistein in water, methanol, ethanol, propan-2-ol, 1-butanol, and ethyl acetate from (280 to 333) K, J. Chem. Eng. Data, 55, 5286, 10.1021/je100261w · DOI
  11. Zhou, 2008, Dose-dependent absorption, metabolism, and excretion of genistein in rats, J. Agric. Food Chem., 56, 8354, 10.1021/jf801051d · DOI
  12. Kwon, 2016, Mitochondria-targeting Ceria nanoparticles as antioxidants for alzheimer's disease, ACS Nano, 10, 2860, 10.1021/acsnano.5b08045 · DOI · Paper page
  13. Parodi, 2013, Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions, Nat. Nanotechnol., 8, 61, 10.1038/nnano.2012.212 · DOI · Paper page
  14. Kroll, 2017, Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity, Adv. Mater., 29, 10.1002/adma.201703969 · DOI · Paper page
  15. Ma, 2019, Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membrane of engineered neural stem cells, Small, 15, 10.1002/smll.201902011 · DOI · Paper page
  16. Fang, 2017, Cell membrane-derived nanomaterials for biomedical applications, Biomaterials, 128, 69, 10.1016/j.biomaterials.2017.02.041 · DOI · Paper page
  17. Zhao, 2011, Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles, Nanomedicine, 6, 25, 10.2217/nnm.10.129 · DOI · Paper page
  18. Brynskikh, 2010, Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease, Nanomedicine, 5, 379, 10.2217/nnm.10.7 · DOI · Paper page
  19. Cao, 2016, Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer, ACS Nano, 10, 7738, 10.1021/acsnano.6b03148 · DOI · Paper page
  20. Zhang, 2018, Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy, Nano Lett., 18, 1908, 10.1021/acs.nanolett.7b05263 · DOI · Paper page
  21. Fu, 2019, Dual-modified novel biomimetic nanocarriers improve targeting and therapeutic efficacy in glioma, ACS Appl. Mater. Interfaces, 11, 1841, 10.1021/acsami.8b18664 · DOI · Paper page
  22. Park, 2015, Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer's disease, Biomaterials, 38, 61, 10.1016/j.biomaterials.2014.10.068 · DOI
  23. Cui, 2019, RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease, Immun. Ageing, 16, 10.1186/s12979-019-0150-2 · DOI · Paper page
  24. Marrache, 2012, Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics, Proc. Natl. Acad. Sci. U.S.A., 109, 16288, 10.1073/pnas.1210096109 · DOI · Paper page
  25. Baron-Bodo, 2005, Anti-tumor properties of human-activated macrophages produced in large scale for clinical application, Immunobiology, 210, 267, 10.1016/j.imbio.2005.05.021 · DOI
  26. Wang, 2015, In vitro model of the blood-brain barrier established by co-culture of primary cerebral microvascular endothelial and astrocyte cells, Neural Regen. Res., 10, 2011, 10.4103/1673-5374.172320 · DOI
  27. Zhang, 2015, Micellar emulsions composed of mPEG-PCL/MCT as novel nanocarriers for systemic delivery of genistein: a comparative study with micelles, Int. J. Nanomed., 10, 6175
  28. Wang, 2010, Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species, J. Biol. Inorg. Chem., 15, 1087, 10.1007/s00775-010-0668-4 · DOI
  29. Soucy, 2006, Kinetics of genistein and its conjugated metabolites in pregnant Sprague-Dawley rats following single and repeated genistein administration, Toxicol. Sci., 90, 230, 10.1093/toxsci/kfj077 · DOI
  30. Yao, 2016, Nanoformulated alpha-mangostin ameliorates Alzheimer's disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance, J. Contr. Release, 226, 1, 10.1016/j.jconrel.2016.01.055 · DOI
  31. Zhao, 2012, Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine(R-15) triblock copolymer for siRNA delivery, Biomaterials, 33, 6793, 10.1016/j.biomaterials.2012.05.067 · DOI
  32. Baer, 1990, Rabies susceptibility and acetylcholine-receptor, Lancet, 335, 664, 10.1016/0140-6736(90)90454-D · DOI
  33. Biswas, 2012, Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo, J. Contr. Release, 159, 393, 10.1016/j.jconrel.2012.01.009 · DOI · Paper page
  34. Wang, 2016, Mitochondria as a therapeutic target in Alzheimer's disease, Genes Dis., 3, 220, 10.1016/j.gendis.2016.05.001 · DOI · Paper page
  35. Qian, 2015, Protection by genistein on cortical neurons against oxidative stress injury via inhibition of NF-kappaB, JNK and ERK signaling pathway, Pharm. Biol., 53, 1124, 10.3109/13880209.2014.962057 · DOI
  36. Zhang, 2013, Edaravone ameliorates oxidative damage associated with A beta 25-35 treatment in PC12 cells, J. Mol. Neurosci., 50, 494, 10.1007/s12031-013-9973-z · DOI
  37. Greenhalgh, 2020, Immune cell regulation of glia during CNS injury and disease, Nat. Rev. Neurosci., 21, 139, 10.1038/s41583-020-0263-9 · DOI · Paper page
  38. Hinde, 2017, Pair correlation rnicroscopy reveals the role of nanoparticle shape in intracellular transport and site of drug release, Nat. Nanotechnol., 12, 81, 10.1038/nnano.2016.160 · DOI · Paper page
  39. Marrache, 2012, Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics, Proc. Natl. Acad. Sci. U.S.A., 109, 16288, 10.1073/pnas.1210096109 · DOI · Paper page

Cited by

See all 197

Metadata

Authors
Han, Y., Gao, C., Wang, H., Sun, J., Liang, M., Feng, Y., Liu, Q., Fu, S., Cui, L., Gao, C., Li, Y., Yang, Y., & Sun, B.
Venue
Bioactive Materials
Publisher
Elsevier BV
Published
2021-02
Volume
6
Issue
2
Pages
529-542
ISSN
  • 2097-1192 (ISSN-L)
  • 2452-199X
OpenAlex
W3086867618
Cited by
197
References
12
FWCI
5.27
Type
journal article
Language
en
Update notices
erratum (2022-01-01)
Open access
gold
Licence
Funders
  • National Science and Technology Major Projects for Major New Drugs Innovation and Development (2018ZX09711003-008-001)
  • Beijing Natural Science Foundation (7172162)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.